Corsano Health B.V. is a leading MedTech company that develops, manufactures and markets medical-grade wearables and cloud solutions for continuous, real-time remote patient monitoring. Based in the Netherlands with offices in Switzerland, Corsano provides CE-MDR certified and FDA-cleared solutions powered by its multi-sensor CardioWatch platform for hospital, research and home-monitoring environments. Corsano’s open APIs and access to raw and processed data enable partners worldwide to integrate continuous monitoring into clinical workflows, conduct advanced research and develop next-generation AI algorithms to improve patient outcomes.
Mission: Cancer
HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancersHORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative careHORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients